رجوع
نطاق اليوم
KWD 5.25
KWD 5.54
نطاق 52 أسبوعًا
KWD 3.81
KWD 10.08
حجم التداول
1,873,971
متوسط 50 يوم / 200 يوم
KWD 6.75
/
KWD 6.88
الإغلاق السابق
KWD 5.61
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 1646.5 | 0.3 |
| P/B | 66.6 | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | 0.2 | 3.8 |
| Rev Growth 5Y % | 55.8 | 10.0 |
| D/E | 2.8 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 13.500
+155.2%
Low: KWD 9.000
High: KWD 18.000
مكرر الربحية المستقبلي
46.8
ربحية السهم المستقبلية
KWD 0.120
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
380 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 1.090
KWD 1.060 – KWD 1.137
|
700 M | 1 |
| FY2029 |
KWD 0.890
KWD 0.866 – KWD 0.928
|
610 M | 1 |
| FY2028 |
KWD 0.586
KWD 0.378 – KWD 0.819
|
540 M | 5 |
النقاط الرئيسية
Revenue grew 55.75% annually over 5 years — strong growth
Debt/Equity of 2.76 — high leverage
Generating 27.93M in free cash flow
P/E of 1646.50 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 12.03%
Cash machine — converts 5041.52% of earnings into free cash flow
النمو
Revenue Growth (5Y)
55.75%
Revenue (1Y)43.72%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
N/A
ROIC36.29%
Net Margin0.19%
Op. Margin8.53%
الأمان
Debt / Equity
2.76
Current Ratio2.19
Interest Coverage0.86
التقييم
P/E Ratio
1646.50
P/B Ratio66.63
EV/EBITDA33.70
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 43.72% | Revenue Growth (3Y) | 33.43% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 55.75% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 291.85M | Net Income (TTM) | 554,000.0 |
| ROE | N/A | ROA | 0.14% |
| Gross Margin | 81.70% | Operating Margin | 8.53% |
| Net Margin | 0.19% | Free Cash Flow (TTM) | 27.93M |
| ROIC | 36.29% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2.76 | Current Ratio | 2.19 |
| Interest Coverage | 0.86 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 1646.50 | P/B Ratio | 66.63 |
| P/S Ratio | 3.13 | PEG Ratio | -22.52 |
| EV/EBITDA | 33.70 | Dividend Yield | 0.00% |
| Market Cap | 912.16M | Enterprise Value | 838.88M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 291.85M | 203.07M | 163.91M | 110.25M | 49.59M |
| Net Income | 554,000.0 | -54.84M | -62.26M | -94.66M | -122.73M |
| EPS (Diluted) | 0.00 | -0.37 | -0.45 | -0.70 | -1.55 |
| Gross Profit | 238.43M | 166.24M | 135.27M | 87.61M | 36.27M |
| Operating Income | 24.90M | -33.65M | -44.01M | -81.94M | -115.16M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 383.53M | 323.06M | 322.60M | 344.52M | 304.36M |
| Total Liabilities | 369.84M | 352.68M | 329.38M | 299.34M | 209.13M |
| Shareholders' Equity | 13.69M | -29.62M | -6.78M | 45.19M | 95.23M |
| Total Debt | 37.76M | 271.45M | 229.19M | 198.06M | 88.07M |
| Cash & Equivalents | 111.04M | 71.62M | 67.45M | 121.97M | 67.27M |
| Current Assets | 240.31M | 167.66M | 156.26M | 186.82M | 142.60M |
| Current Liabilities | 109.57M | 100.44M | 95.19M | 73.62M | 79.04M |